Authors: Kereiakes, DJ Broderick, TM Roth, EM Whang, D Mueller, M Lacock, P Anderson, LC Howard, W Blanck, C Schneider, J Abbottsmith, CA

Citation: Dj. Kereiakes et al., High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists, J THROMB TH, 9(2), 2000, pp. 149-155

Authors: Knoblauch, H Thiel, G Tinschert, S Korner, H Tennstedt, C Chaoui, R Kohlhase, J Dixkens, C Blanck, C

Citation: H. Knoblauch et al., Clinical and molecular cytogenetic studies of a large de novo interstitialdeletion 16q11.2-16q21 including the putative transcription factor gene SALL1, J MED GENET, 37(5), 2000, pp. 389-392

Authors: Blanck, C Kohlhase, J Engels, P Burfeind, P Engel, W Bottani, A Patel, MS Kroes, HY Cobben, JM

Citation: C. Blanck et al., Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndrome, J MED GENET, 37(4), 2000, pp. 303-307

Authors: Kohlhase, J Taschner, PEM Burfeind, P Pasche, B Newman, B Blanck, C Breuning, MH ten Kate, LP Maaswinkel-Mooy, P Mitulla, B Seidel, J Kirkpatrick, SJ Pauli, RM Wargowski, DS Devriendt, K Proesmans, W Gabrielli, O Coppa, GV Wesby-van Swaay, E Trembath, RC Schinzel, AA Reardon, W Seemanova, E Engel, W

Citation: J. Kohlhase et al., Molecular analysis of SALL1 mutations in Townes-Brocks syndrome, AM J HU GEN, 64(2), 1999, pp. 435-445